Literature DB >> 6683814

Evaluating the evaluations: or how to weigh the scales of parkinsonian disability.

S G Diamond, C H Markham.   

Abstract

We used four disability scales to evaluate eight patients with Parkinson's disease who were treated with pergolide mesylate for 1 year. Disability was rated on all four scales by the same neurologist at each of 11 visits. Prior ratings were not available to the examiner, who did not know that the scales themselves were an object of study. Disability scores, converted to percentage improvement relative to baseline, varied considerably between scales; for instance, at 5 months, one showed 13% improvement and another 58%. At 9 months, one showed worsening of 6% and another showed improvement of 34%. The four disability scales clearly measure different aspects of parkinsonism, and comparing results of different studies may not be valid if the disability scales are not the same.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683814     DOI: 10.1212/wnl.33.8.1098

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity.

Authors:  L Henderson; C Kennard; T J Crawford; S Day; B S Everitt; S Goodrich; F Jones; D M Park
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

2.  A controlled, longitudinal study of dementia in Parkinson's disease.

Authors:  C A Biggins; J L Boyd; F M Harrop; P Madeley; R H Mindham; J I Randall; E G Spokes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

Review 3.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

4.  The Effect of Balance Training by Tetraks Interactive Balance System on Balance and Fall Risk in Parkinson's Patients: A Report of Four Cases.

Authors:  Nilay Çömük Balci; Eda Tonga; Mustafa Gülşen
Journal:  Noro Psikiyatr Ars       Date:  2013-09-01       Impact factor: 1.339

5.  Quality of life in patients with Parkinson's disease: development of a questionnaire.

Authors:  A G de Boer; W Wijker; J D Speelman; J C de Haes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 6.  Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease.

Authors:  H D Langtry; S P Clissold
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

7.  Depression in Parkinson disease: a disabling but neglected factor.

Authors:  R Cantello; A Riccio; L Scarzella; D Leotta; B Bergamasco
Journal:  Ital J Neurol Sci       Date:  1984-12

8.  Comparison of Quantitative Electroencephalogram During Sleep in Depressed and Non-Depressed Patients with Parkinson's Disease.

Authors:  Ke Liu; QinYing Ma; MingWei Wang
Journal:  Med Sci Monit       Date:  2019-02-07

Review 9.  Quality of life in Parkinson's disease.

Authors:  J A Opara; W Brola; M Leonardi; B Błaszczyk
Journal:  J Med Life       Date:  2012-12-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.